A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/1999
10/21/1999	WO1999052554A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
10/21/1999	WO1999052553A1 Methods and compositions using cetirizine in combination with leukotriene inhibitors for treating conditions responsive to leukotriene inhibition
10/21/1999	WO1999052538A1 Composition containing a herbal medicinal substance and a pharmaceutical drug
10/21/1999	WO1999052536A1 Use of at least a plant extract of the compositae family, such as the genus bellis
10/21/1999	WO1999052524A1 Use of cannabinoids as anti-inflammatory agents
10/21/1999	WO1999052514A2 Pharmaceutical composition and combination preparation for immunosuppressive therapy
10/21/1999	WO1999052508A1 Method for the treatment of asthma
10/21/1999	WO1999052493A2 Compounds that inhibit the binding of integrins to their receptors
10/21/1999	WO1995026768A9 Methods for treating pulmonary vasoconstriction and asthma
10/21/1999	DE19816857A1 Novel adenosine antagonists useful in treatment of e.g. neurodegenerative, pulmonary, renal and cardiovascular disorders
10/21/1999	CA2328344A1 Method for the treatment of asthma
10/21/1999	CA2328250A1 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds
10/21/1999	CA2328245A1 Phosphodiesterase isoenzyme denominated 4 (pde 4) inhibiting compounds
10/21/1999	CA2328075A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors
10/21/1999	CA2327431A1 Pharmaceutical composition
10/20/1999	EP0950657A2 Substituted carbazoles, process for their preparation and their use as sPLA2 inhibitors
10/20/1999	EP0950412A2 Compositions for treating allergic disorders using (-) cetirizine
10/20/1999	EP0950101A1 Secreted proteins and polynucleotides encoding them
10/20/1999	EP0950100A1 Keratinocyte growth factor-2 (kgf-2 or fibroblast growth factor-12, fgf-12)
10/20/1999	EP0950058A1 Spiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonists
10/20/1999	EP0950046A1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators
10/20/1999	EP0949929A1 Use of plant extract for inhibition of haemophilus influenzae
10/20/1999	CN1232457A 1,4-heterocyclic metalloprotease inhibitors
10/20/1999	CN1232456A PDE IV inhibiting 2-cyanoiminoimidazole derivs.
10/20/1999	CN1232398A IL-8 receptor antagonists
10/20/1999	CN1232397A Use of H+, K+-ATPase inhibitor in treatment of nasal polyps
10/20/1999	CN1231899A Medicinal patch for treatment of cough and asthma
10/20/1999	CN1045778C Novel chemical compounds having P.DE-IV inhibition activity
10/20/1999	CN1045777C Tetracyclic derivs. process of preparation and use
10/19/1999	US5969184 Amide compounds
10/19/1999	US5969158 Administering derivatives of homoserine lactone to inhibit histamine release from mast cells and/or basophils
10/19/1999	US5969134 Cardiovascular disorders, vasoconstriction, hypotensive agents and release of endothelins
10/19/1999	US5969093 Secreted proteins
10/19/1999	US5968978 Antiarrythmia agents, antiischemic agents, inhibit proliferation of cells
10/19/1999	US5968923 (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/19/1999	US5968920 Increase glutathione peroxidase activity for reducing levels of peroxides in cells or tissues
10/19/1999	US5968826 Antisense inhibition of integrin α4 expression
10/19/1999	US5968777 DNA encoding seryl t-RNA synthetase
10/19/1999	US5968776 Multimeric hybrid gene encoding a chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
10/17/1999	CA2269262A1 Substituted tricyclics
10/14/1999	WO1999051626A2 Template associated npy y2-receptor agonists
10/14/1999	WO1999051605A1 PYRROLO[1,2-a]PYRAZINE sPLA2 INHIBITOR
10/14/1999	WO1999051205A1 Aerosol composition
10/14/1999	WO1999051188A2 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999	WO1999039729A3 Use of heregulin as an epithelial cell growth factor
10/14/1999	WO1999026604A3 Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
10/14/1999	DE19913089A1 Composition comprising plant extracts from at least two of Bryonia, Ipecacuanha or Drosera, and antimony potassium tartrate, useful for treatment of chronic obstructive pulmonary disease, bronchitis, respiratory disorders and cancer
10/14/1999	CA2326522A1 Pyrrolo¬1,2-a\|pyrazine spla2 inhibitor
10/14/1999	CA2326388A1 A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
10/14/1999	CA2326146A1 Template associated npy y2-receptor agonists
10/13/1999	EP0949245A1 Process for alkylating hindered sulfonamides
10/13/1999	EP0948620A2 Secreted proteins and polynucleotides encoding them
10/13/1999	EP0948605A1 Truncated platelet-activating factor acetylhydrolase
10/13/1999	EP0948544A1 Monovalent antibody fragments
10/13/1999	EP0948521A1 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
10/13/1999	EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999	EP0948509A1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
10/13/1999	EP0948500A1 Cyclic organoselenium compounds, their preparation and their uses
10/13/1999	EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999	EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999	EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999	EP0695185B1 Use of adenosine for the manufacture of a medicament for the treatment of pulmonary inflammatory reactions
10/13/1999	CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin
10/13/1999	CN1231601A Oral delayed immediate release formulation and method of preparation therefor
10/13/1999	CN1045601C Novel quinuclidine derivatives and medicinal composition thereof
10/13/1999	CN1045596C Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
10/13/1999	CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
10/12/1999	US5965745 Asthma; antiarthritic,-shock agents; bronchitis; respiratory system diseases, e.g. chronic obstructive airways diseases; psoriasis; allergic rhinitis; atopic dermatitis
10/12/1999	US5965622 Bronchodilators; highly selective beta 2-adrenergic receptor agonist; respiratory disorders, e.g. asthma, bronchitis; reduction of a protected nitro derivative; stereospecific
10/12/1999	US5965586 Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation
10/12/1999	US5965585 Suppressing formation of collagen and collagen-like substances or biosynthesis of procollagen in living systems by administering a hydroxypyridone compound enzyme inhibitor of protein hydroxylase; antiscarring agents
10/12/1999	US5965582 Antihistamines
10/12/1999	US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999	US5965576 A nonpeptide antagonists of neurokinin a for treating respiratory system disorders
10/12/1999	US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999	US5965562 Treating disorders induced by substance p and migraine headache
10/12/1999	US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999	US5965416 Arginyl tRNA synthetase from staphyloccus aureus
10/12/1999	US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999	US5965365 A human growth factor receptor binding gene; treatment and diagnosis of smooth muscle disorders; antiproliferative/ anticarcinogenic/antitumor agents
10/07/1999	WO1999050657A1 Corticotropin releasing factor receptor 1-deficient mice
10/07/1999	WO1999050262A1 Pde iv inhibiting pyridine derivatives
10/07/1999	WO1999050248A1 Pyridazinone hydrochloride compound and method for producing the same
10/07/1999	WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999	WO1999049856A2 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999	WO1999049855A2 Ipg antagonists for the treatment of conditions involving mast cells, basophils and eosinophils
10/07/1999	WO1999027924A3 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
10/07/1999	CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999	CA2326506A1 Pyridazinone hydrochloride compound and method for producing the same
10/07/1999	CA2325986A1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
10/07/1999	CA2325721A1 Corticotropin releasing factor receptor 1-deficient mice
10/07/1999	CA2319588A1 Materials and methods relating to the treatment of conditions involving mast cells basophils and eosinophils
10/06/1999	EP0947496A1 Bicyclic aromatic compounds and their use in human and veterinary medicine as well as in cosmetology
10/06/1999	EP0946587A2 New amide compounds
10/06/1999	EP0946568A1 Use of 7-alkylidene cephalosporins to inhibit elastase activity
10/06/1999	EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS
10/06/1999	EP0946561A1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments
10/06/1999	EP0946557A1 A-1-adenosine receptor antagonists
10/06/1999	EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/06/1999	EP0946548A1 Novel heterocyclic substituted pyrrolidine amide derivatives

1 ... 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 ... 878